Molecular hydrogen treatment improves cognitive problems in Alzheimer's model
We conclude that the dose of 3 mg/kg promotes cognitive and respiratory changes present in AD, thus becoming a dose for a model of sporadic Alzheimer's in the intermediate and late window of the disease. In addition, treatment with H<sub>2</sub> gas is effective in promoting improvements in the cognition of animals, making it a potential therapeutic candidate for AD.
Authors
- Arthur Dalmolin DAHMER
- Kênia C. Bícego (ORCID: https://orcid.org/0000-0002-1180-1132)
- Mariane C. Vicente (ORCID: https://orcid.org/0000-0002-6389-7164)
- Luciane Helena Gargaglioni Batalhão
Institutions
- Núcleo de Pesquisas Aplicadas (Brazil) (BR)
- Universidade Estadual Paulista (Unesp) (BR)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70855_100382
- Primary Topic
- Hydrogen's biological and therapeutic effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00